AVANIR Pharmaceuticals (AMEX: AVN) announced that a Phase I study has been initiated in partnership with AstraZeneca ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE